BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 32843909)

  • 1. Prostate cancer management: long-term beliefs, epidemic developments in the early twenty-first century and 3PM dimensional solutions.
    Kucera R; Pecen L; Topolcan O; Dahal AR; Costigliola V; Giordano FA; Golubnitschaja O
    EPMA J; 2020 Sep; 11(3):399-418. PubMed ID: 32843909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The paradigm change from reactive medical services to 3PM in ischemic stroke: a holistic approach utilising tear fluid multi-omics, mitochondria as a vital biosensor and AI-based multi-professional data interpretation.
    Golubnitschaja O; Polivka J; Potuznik P; Pesta M; Stetkarova I; Mazurakova A; Lackova L; Kubatka P; Kropp M; Thumann G; Erb C; Fröhlich H; Wang W; Baban B; Kapalla M; Shapira N; Richter K; Karabatsiakis A; Smokovski I; Schmeel LC; Gkika E; Paul F; Parini P; Polivka J
    EPMA J; 2024 Mar; 15(1):1-23. PubMed ID: 38463624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic Effects Reflected in Specific Biomarker Patterns Are Instrumental for the Paradigm Change in Prostate Cancer Management: A Strategic Paper.
    Golubnitschaja O; Kubatka P; Mazurakova A; Samec M; Alajati A; Giordano FA; Costigliola V; Ellinger J; Ritter M
    Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ischemic stroke of unclear aetiology: a case-by-case analysis and call for a multi-professional predictive, preventive and personalised approach.
    Golubnitschaja O; Potuznik P; Polivka J; Pesta M; Kaverina O; Pieper CC; Kropp M; Thumann G; Erb C; Karabatsiakis A; Stetkarova I; Polivka J; Costigliola V
    EPMA J; 2022 Dec; 13(4):535-545. PubMed ID: 36415625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-prostate cancer protection and therapy in the framework of predictive, preventive and personalised medicine - comprehensive effects of phytochemicals in primary, secondary and tertiary care.
    Mazurakova A; Samec M; Koklesova L; Biringer K; Kudela E; Al-Ishaq RK; Pec M; Giordano FA; Büsselberg D; Kubatka P; Golubnitschaja O
    EPMA J; 2022 Sep; 13(3):461-486. PubMed ID: 35821883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. All around suboptimal health - a joint position paper of the Suboptimal Health Study Consortium and European Association for Predictive, Preventive and Personalised Medicine.
    Wang W; Yan Y; Guo Z; Hou H; Garcia M; Tan X; Anto EO; Mahara G; Zheng Y; Li B; Kang T; Zhong Z; Wang Y; Guo X; Golubnitschaja O;
    EPMA J; 2021 Dec; 12(4):403-433. PubMed ID: 34539937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caution, "normal" BMI: health risks associated with potentially masked individual underweight-EPMA Position Paper 2021.
    Golubnitschaja O; Liskova A; Koklesova L; Samec M; Biringer K; Büsselberg D; Podbielska H; Kunin AA; Evsevyeva ME; Shapira N; Paul F; Erb C; Dietrich DE; Felbel D; Karabatsiakis A; Bubnov R; Polivka J; Polivka J; Birkenbihl C; Fröhlich H; Hofmann-Apitius M; Kubatka P
    EPMA J; 2021 Sep; 12(3):243-264. PubMed ID: 34422142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Energy metabolism as the hub of advanced non-small cell lung cancer management: a comprehensive view in the framework of predictive, preventive, and personalized medicine.
    Bajinka O; Ouedraogo SY; Golubnitschaja O; Li N; Zhan X
    EPMA J; 2024 Jun; 15(2):289-319. PubMed ID: 38841622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Making a complex dental care tailored to the person: population health in focus of predictive, preventive and personalised (3P) medical approach.
    Tachalov VV; Orekhova LY; Kudryavtseva TV; Loboda ES; Pachkoriia MG; Berezkina IV; Golubnitschaja O
    EPMA J; 2021 Jun; 12(2):129-140. PubMed ID: 33897916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Minderoo-Monaco Commission on Plastics and Human Health.
    Landrigan PJ; Raps H; Cropper M; Bald C; Brunner M; Canonizado EM; Charles D; Chiles TC; Donohue MJ; Enck J; Fenichel P; Fleming LE; Ferrier-Pages C; Fordham R; Gozt A; Griffin C; Hahn ME; Haryanto B; Hixson R; Ianelli H; James BD; Kumar P; Laborde A; Law KL; Martin K; Mu J; Mulders Y; Mustapha A; Niu J; Pahl S; Park Y; Pedrotti ML; Pitt JA; Ruchirawat M; Seewoo BJ; Spring M; Stegeman JJ; Suk W; Symeonides C; Takada H; Thompson RC; Vicini A; Wang Z; Whitman E; Wirth D; Wolff M; Yousuf AK; Dunlop S
    Ann Glob Health; 2023; 89(1):23. PubMed ID: 36969097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive, preventive and personalised approach as a conceptual and technological innovation in primary and secondary care of inflammatory bowel disease benefiting affected individuals and populations.
    Arosa L; Camba-Gómez M; Golubnitschaja O; Conde-Aranda J
    EPMA J; 2024 Mar; 15(1):111-123. PubMed ID: 38463620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Dry mouth" and "Flammer" syndromes-neglected risks in adolescents and new concepts by predictive, preventive and personalised approach.
    Kunin A; Polivka J; Moiseeva N; Golubnitschaja O
    EPMA J; 2018 Sep; 9(3):307-317. PubMed ID: 30174766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mass spectrometry analysis of human tear fluid biomarkers specific for ocular and systemic diseases in the context of 3P medicine.
    Zhan X; Li J; Guo Y; Golubnitschaja O
    EPMA J; 2021 Dec; 12(4):449-475. PubMed ID: 34876936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate cancer treatment costs increase more rapidly than for any other cancer-how to reverse the trend?
    Ellinger J; Alajati A; Kubatka P; Giordano FA; Ritter M; Costigliola V; Golubnitschaja O
    EPMA J; 2022 Mar; 13(1):1-7. PubMed ID: 35251382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flavonoids against the Warburg phenotype-concepts of predictive, preventive and personalised medicine to cut the Gordian knot of cancer cell metabolism.
    Samec M; Liskova A; Koklesova L; Samuel SM; Zhai K; Buhrmann C; Varghese E; Abotaleb M; Qaradakhi T; Zulli A; Kello M; Mojzis J; Zubor P; Kwon TK; Shakibaei M; Büsselberg D; Sarria GR; Golubnitschaja O; Kubatka P
    EPMA J; 2020 Sep; 11(3):377-398. PubMed ID: 32843908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liquid Biopsy is Instrumental for 3PM Dimensional Solutions in Cancer Management.
    Liskova A; Samec M; Koklesova L; Giordano FA; Kubatka P; Golubnitschaja O
    J Clin Med; 2020 Aug; 9(9):. PubMed ID: 32854390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Past, Current, and Future Incidence Rates and Burden of Metastatic Prostate Cancer in the United States.
    Kelly SP; Anderson WF; Rosenberg PS; Cook MB
    Eur Urol Focus; 2018 Jan; 4(1):121-127. PubMed ID: 29162421
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.